Korean J Fam Pract. 2017; 7(6): 818-823  https://doi.org/10.21215/kjfp.2017.7.6.818
The Correlationship between the Ratio of Triglyceride to High-Density Lipoprotein Cholesterol and Non-Alcoholic Fatty Liver Disease
Han Na Seo1, Hye Mi Lee1, Tai Chi Lin1, Joon Suk Oh1, Hye Rim Kong2, Sung A Cho2, Bong Gyu Choi1,*
1Department of Family Medicine, Gwangmyeong Sungae Hospital, Gwangmyeong; 2Department of Family Medicine, Sungae Hospital, Seoul, Korea
Bong Gyu Choi
Tel: +82-2-2680-7114, Fax: +82-2-2680-7755
E-mail: stapy74@hanmail.net
Received: March 3, 2017; Revised: April 30, 2017; Accepted: May 26, 2017; Published online: December 20, 2017.
© Korean Academy of Family Medicine. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background: This study aimed to elucidate the relationship between the ratio of triglyceride (TG) to high-density lipoprotein cholesterol (HDL-C) and non-alcoholic fatty liver disease (NAFLD).
Methods: A total of 724 subjects were screened at the health center of a Gwangmyeong Sungae Hospital in 2015. Of those screened, 389 were selected after excluding subjects with significant alcohol consumption, evidence of viral or toxic hepatitis, significant liver or renal dysfunction, or other disease. All subjects underwent anthropometric measurement, laboratory examination, and abdominal ultrasonography. We compared the ratio of TG to HDL-C between the NAFLD group and the control group to identify a correlation. The ratio of TG to HDL-C was divided into quartiles and the prevalence of NAFLD was determined.
Results: The prevalence of NAFLD was 45.2%. The prevalence of hypertriglyceridemia, low HDL-C, hyperglycemia, and obesity was higher in the NAFLD group than in the control group. In addition, the ratio of TG to HDL-C was higher in the NAFLD group than in the control group. As the ratio of TG to HDL-C increased, the odds ratio and 95% confidence interval for the prevalence of NAFLD showed a tendency toward a significant increase in both in adjusted and unadjusted models.
Conclusion: The ratio of TG to HDL-C was closely correlated with NAFLD.
Keywords: High Density Lipoprotein Cholesterol; Dyslipidemia; Non-Alcoholic Fatty Liver Disease; Ultrasonography
References
  1. Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006; 21: 138-43.
    Pubmed CrossRef
  2. Bae JC, Cho YK, Lee WY, Seo HI, Rhee EJ, Park SE, et al. Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects. Am J Gastroenterol 2010; 105: 2389-95.
    Pubmed CrossRef
  3. Choi SY, Kim D, Kim HJ, Kang JH, Chung SJ, Park MJ, et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol 2009; 104: 1953-60.
    Pubmed CrossRef
  4. Sung KC, Reaven G, Kim S. Ability of the plasma concentration ratio of triglyceride/high-density lipoprotein cholesterol to identify increased cardiometabolic risk in an east Asian population. Diabetes Res Clin Pract 2014;105: 96-101.
    Pubmed CrossRef
  5. Salazar MR, Carbajal HA, Espeche WG, Leiva Sisnieguez CE, Balbín E, Dulbecco CA, et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol 2012; 109:1749-53.
    Pubmed CrossRef
  6. Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Leiva Sisnieguez CE, Leiva Sisnieguez BC, et al. Use of the plasma triglyceride/high-density lipoprotein cholesterol ratio to identify cardiovascular disease in hypertensive subjects. J Am Soc Hypertens 2014; 8: 724-31.
    Pubmed CrossRef
  7. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. High triglycerides/low highdensity lipoprotein cholesterol, ischemic electrocardiogram changes, and risk of ischemic heart disease. Am Heart J 2003; 145: 103-8.
    Pubmed CrossRef
  8. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 2010; 55: 560-78.
    Pubmed CrossRef
  9. Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006; 29: 1325-30.
    Pubmed CrossRef
  10. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30: 1212-8.
    Pubmed CrossRef
  11. Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 2011; 54: 344-53.
    Pubmed KoreaMed CrossRef
  12. Loria P, Adinolfi LE, Bellentani S, Bugianesi E, Grieco A, Fargion S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010; 42: 272-82.
    Pubmed CrossRef
  13. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-23.
    Pubmed CrossRef
  14. Kim MY. The diagnosis of nonalcoholic fatty liver disease. Korean J Med 2014; 86: 405-15.
    CrossRef
  15. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-5.
    Pubmed KoreaMed CrossRef
  16. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008; 118: 829-38.
    Pubmed KoreaMed CrossRef
  17. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 1343-51.
    Pubmed KoreaMed CrossRef
  18. Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87: 30238.
    Pubmed CrossRef
  19. Struben VM, Hespenheide EE, Caldwell SH. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 2000; 108: 9-13.
    CrossRef
  20. Salazar MR, Carbajal HA, Espeche WG, Leiva Sisnieguez CE, March CE, Balbín E, et al. Comparison of the abilities of the plasma triglyceride/highdensity lipoprotein cholesterol ratio and the metabolic syndrome to identify insulin resistance. Diab Vasc Dis Res 2013; 10: 346-52.
    Pubmed CrossRef
  21. Kim-Dorner SJ, Deuster PA, Zeno SA, Remaley AT, Poth M. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? Metabolism 2010; 59: 299-304.
    Pubmed CrossRef


This Article

e-submission

Archives